Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Repeat liver resection for hepatocellular carcinoma.

Y Nakajima1, S Ko, T Kanamura

  • 1First Department of Surgery, Nara Medical University, Japan.

Journal of the American College of Surgeons
|March 14, 2001
PubMed
Summary

Second liver resection for recurrent hepatocellular carcinoma (HCC) is safe but offers low disease-free survival. Careful patient selection is crucial for repeat hepatectomy success in managing HCC recurrence.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prognostic significance of the prognostic nutritional index in esophageal cancer patients undergoing neoadjuvant chemotherapy.

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·2017
Same author

Clinical importance of B7-H3 expression in human pancreatic cancer.

British journal of cancer·2009
Same author

Protective effect of prostaglandin E2 receptors EP2 and EP4 in alloimmune response in vivo.

Transplantation proceedings·2006
Same author

A novel CCR5/CXCR3 antagonist protects intestinal ischemia/reperfusion injury.

Transplantation proceedings·2006
Same author

In vivo engineering of metabolically active hepatic tissues in a neovascularized subcutaneous cavity.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2006
Same author

Heterotopically transplanted hepatocyte survival depends on extracellular matrix components.

Transplantation proceedings·2006

Area of Science:

  • Hepatobiliary Surgery
  • Surgical Oncology
  • Gastroenterology

Background:

  • Hepatectomy is a standard treatment for primary hepatocellular carcinoma (HCC).
  • The efficacy of repeat liver resection for intrahepatic HCC recurrence after initial surgery remains under-evaluated.
  • Understanding outcomes of second liver resections is critical for managing recurrent HCC.

Purpose of the Study:

  • To evaluate the safety and efficacy of repeat liver resection for intrahepatic recurrence of HCC.
  • To compare outcomes of second hepatectomy with nonsurgical ablative therapy for recurrent HCC.
  • To identify factors influencing survival and disease-free survival after repeat liver resection.

Main Methods:

  • Retrospective review of 94 patients who underwent curative liver resection for HCC between 1991 and 1996.

Related Experiment Videos

  • Analysis of 57 patients with isolated liver recurrence: 12 underwent repeat resection, 45 received nonsurgical therapy.
  • Data collected on operative morbidity, mortality, survival, disease-free survival, and failure patterns.

    • Main Results:

    • Second liver resections for recurrent HCC had no perioperative deaths and comparable morbidity to initial resections.
    • Disease-free survival at 2 years was 31% after second hepatectomy, significantly lower than 62% after initial hepatectomy (p=0.009).
    • Overall survival at 2 years was 90% after second hepatectomy versus 70% after nonsurgical treatment (p=0.253).

    Conclusions:

    • Repeat liver resection for recurrent HCC can be performed safely and may improve overall survival.
    • The low disease-free survival rate after second hepatectomy highlights the high likelihood of further recurrences.
    • Further research is needed to select patients who will benefit most from repeat liver resection for HCC.